06/29/2020

COVID-19 vaccine being developed at unprecedented speed

By nature, COVID-19 vaccine development is different from previous projects — Dr. Sang-Hwan Seo, Research Scientist & Lab Manager at IVI, explains why:   Since a couple of months ago, signs have been posted outside of IVI’s biosafety level 3 (BSL-3) facility saying that COVID-19 […]
06/29/2020

Planning a COVID-19 vaccine clinical trial at pace with a pandemic

How COVID-19 vaccine clinical trials currently underway around the world may be the blueprint for future clinical trial designs   The team meets at 8:30 AM every morning for a daily “huddle.” All conversation revolves around a whiteboard filled with due dates, action items, pressing […]
07/31/2020

‘Present and Future of Vaccine Development’ Seminar series: Pathogenesis and host immunity in acute model of macaques infected with SARS CoV 2

July 30, 2020, SEOUL, South Korea — We were pleased to welcome Dr. Jung Joo Hong, Director of ABSL-3 at the National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology for a seminar on the suitability of macaques as a non-human primate model […]
08/03/2020

H.E. Michael Danagher visits IVI to discuss COVID-19 vaccine development

  August 3, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) welcomed His Excellency Michael Danagher, Ambassador of Canada to the Koreas, to IVI headquarters today to discuss developments in COVID-19 vaccine research as well as ongoing efforts to sustain programs for long-existing […]